{"id":12526,"date":"2026-01-28T10:17:48","date_gmt":"2026-01-28T10:17:48","guid":{"rendered":"https:\/\/csiag.de\/?p=12526"},"modified":"2026-01-28T12:42:52","modified_gmt":"2026-01-28T12:42:52","slug":"kolloider-saekert-effektiva-eller-inte","status":"publish","type":"post","link":"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/","title":{"rendered":"Kolloider - s\u00e4kert effektiva eller inte?"},"content":{"rendered":"<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_85 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Inneh\u00e5llsf\u00f6rteckning<\/p>\n<span class=\"ez-toc-title-toggle\"><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Silber_Ag\" >Kolloidalt silver (Ag)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Aktueller_wissenschaftlicher_Stand\" >Aktuell vetenskaplig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Vorhandene_Studien_und_deren_Limitationen\" >Befintliga studier och deras begr\u00e4nsningar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Systematische_Reviews_und_Meta-Analysen\" >Systematiska \u00f6versikter och metaanalyser<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Problematik_der_Bioverfugbarkeit\" >Problemet med biotillg\u00e4nglighet<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Regulatorische_Position\" >Reglerande st\u00e4llning<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Dokumentierte_Risiken_bei_oraler_Einnahme\" >Dokumenterade risker med oralt intag<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Gold_Au\" >Kolloidalt guld (Au)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftlicher_Stand\" >Vetenskaplig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Gold_%E2%80%93_Evidenzlage\" >Kolloidalt guld - evidensbas<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Bioverfugbarkeit_und_Pharmakokinetik\" >Biotillg\u00e4nglighet och farmakokinetik<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#24_Sicherheitsprofil\" >2.4 S\u00e4kerhetsprofil<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Kupfer_Cu\" >Kolloidal koppar (Cu)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftlicher_Stand-2\" >Vetenskaplig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_vs_ionisches_Kupfer\" >Kolloidal kontra jonisk koppar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Toxizitatsrisiko\" >Toxicitetsrisk<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Zink_Zn\" >Kolloidal zink (Zn)<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftlicher_Stand-3\" >Vetenskaplig status<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Evidenz_fur_Zink-Supplementierung_nicht_spezifisch_kolloidal\" >Bevis till f\u00f6rm\u00e5n f\u00f6r zinktillskott (inte specifikt kolloidalt)<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kolloidales_Zink_spezifisch\" >Kolloidal zink specifik<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Risiken\" >Risker<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Andere_metallische_Kolloide\" >Andra metallkolloider<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Platin_Palladium_andere_Edelmetalle\" >Platina, palladium, andra \u00e4delmetaller<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Nicht-metallische_Kolloide\" >Icke-metalliska kolloider<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Zusammenfassende_Evidenztabelle\" >Sammanfattad tabell \u00f6ver bevis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-26\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Warum_gibt_es_so_wenig_klinische_Forschung\" >Varf\u00f6r finns det s\u00e5 lite klinisk forskning?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-27\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Strukturelle_Grunde\" >Strukturella orsaker<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-28\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Was_bedeutet_das_fur_die_Interpretation\" >Vad inneb\u00e4r detta f\u00f6r tolkningen?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-29\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Praktische_Konzentrationen_in_kommerziellen_Produkten\" >Praktiska koncentrationer i kommersiella produkter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-30\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Topische_vs_orale_Anwendung_%E2%80%93_ein_wichtiger_Unterschied\" >Topikal vs. oral applicering - en viktig skillnad<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-31\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Belegte_topische_Anwendungen\" >Bepr\u00f6vade topiska till\u00e4mpningar<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-32\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Warum_funktioniert_topisch_aber_nicht_oral\" >Varf\u00f6r fungerar topikalt men inte oralt?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-33\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kritische_Bewertung_von_Anekdoten_und_Erfahrungsberichten\" >Kritisk utv\u00e4rdering av anekdoter och f\u00e4ltrapporter<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-34\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Warum_personliche_Berichte_nicht_ausreichen\" >Varf\u00f6r personliga rapporter inte \u00e4r tillr\u00e4ckliga<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-35\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Was_ware_notig_fur_Evidenz\" >Vad skulle beh\u00f6vas f\u00f6r bevis?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-36\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Wissenschaftliche_Quellen_fur_weitere_Recherche\" >Vetenskapliga k\u00e4llor f\u00f6r vidare forskning<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-37\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Fazit\" >Slutsats<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-38\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Kernaussagen\" >Viktiga budskap<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-39\" href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/#Empfehlungen_aus_wissenschaftlicher_Sicht\" >Rekommendationer ur ett vetenskapligt perspektiv<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n\n<p class=\"wp-block-paragraph\">Detta dokument \u00e4r baserat p\u00e5 publicerade vetenskapliga studier. Det \u00e4r viktigt att f\u00f6rst\u00e5 att avsaknaden av kliniska bevis inte inneb\u00e4r att n\u00e5got \u00e4r ineffektivt, utan endast att otillr\u00e4ckliga vetenskapligt kontrollerade studier har genomf\u00f6rts eller att tidigare studier inte har gett tydliga resultat.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Alla \u201ehemmageneratorer\u201c producerar endast <em>joniserad<\/em> Vatten - inte kolloider! P\u00e5 grund av bristen p\u00e5 laboratoriecertifierad m\u00e4tteknik som \u00e4r tillg\u00e4nglig f\u00f6r lekm\u00e4n (de ofta n\u00e4mnda konduktivitetsm\u00e4tarna ger inga reproducerbara och d\u00e4rmed tillf\u00f6rlitliga data om <em>ppm<\/em> (miljondelar) igen) \u00e4r det alltid ok\u00e4nt vilken \u201edos\u201c man tar. De risker som detta medf\u00f6r \u00e4r m\u00e5nga och b\u00f6r inte underskattas.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">F\u00f6ljande \u00e4r vetenskapligt baserad information f\u00f6r b\u00e4ttre orientering.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Silber_Ag\"><\/span>Kolloidalt silver (Ag)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Aktueller_wissenschaftlicher_Stand\"><\/span>Aktuell vetenskaplig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sammanfattning av bevisen:<\/strong> F\u00f6r oralt intag av kolloidalt silver finns det <strong>Inga kliniska studier<\/strong>, som skulle visa medicinsk effekt vid behandling av sjukdomar som uppfyller normerna f\u00f6r evidensbaserad medicin.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Vorhandene_Studien_und_deren_Limitationen\"><\/span>Befintliga studier och deras begr\u00e4nsningar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>In vitro-studier (laboratoriestudier):<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">M\u00e5nga laboratoriestudier visar p\u00e5 antimikrobiella egenskaper:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Morones et al (2005)<\/strong> i <em>Nanoteknologi<\/em>Silvernanopartiklar visar antibakteriell effekt mot E. coli vid koncentrationer p\u00e5 10-100 \u03bcg\/mL i cellkultur<\/li>\n\n\n\n<li><strong>Rai et al (2012)<\/strong> i <em>Till\u00e4mpad mikrobiologi och bioteknik<\/em>Antimikrobiell aktivitet mot multiresistenta bakterier in vitro<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Viktig begr\u00e4nsning:<\/strong> In vitro-effekter kan inte direkt \u00f6verf\u00f6ras till den m\u00e4nskliga organismen. Matsm\u00e4ltningskanalen, pH-v\u00e4rdet, proteinbindningen och andra faktorer f\u00f6r\u00e4ndrar biotillg\u00e4ngligheten dramatiskt.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Djurf\u00f6rs\u00f6k:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hadrup &amp; Lam (2014)<\/strong> i <em>Reglerande toxikologi och farmakologi<\/em>Systematisk granskning - De flesta djurstudier fokuserar p\u00e5 toxicitet, inte terapeutisk effekt<\/li>\n\n\n\n<li>Vissa djurstudier visar antimikrobiella effekter, men doser och f\u00f6rh\u00e5llanden \u00e4r inte \u00f6verf\u00f6rbara till m\u00e4nniskor<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Studier p\u00e5 m\u00e4nniska:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Det finns <strong>Inga publicerade randomiserade, placebokontrollerade dubbelblinda studier (RCT)<\/strong>, som bevisar effektiviteten av kolloidalt silver som tas oralt vid behandling av infektioner eller andra sjukdomar.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Systematische_Reviews_und_Meta-Analysen\"><\/span>Systematiska \u00f6versikter och metaanalyser<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Cochrane-databasen (2023):<\/strong> Inga poster f\u00f6r oralt intag av kolloidalt silver mot infektioner<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Hadrup et al (2018)<\/strong> i <em>Reglerande toxikologi och farmakologi<\/em>:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Omfattande genomg\u00e5ng av silver i medicinska till\u00e4mpningar<\/li>\n\n\n\n<li>Slutsats: Topikal applicering dokumenterad, oral applicering otillr\u00e4ckligt unders\u00f6kt<\/li>\n\n\n\n<li>Inga tillr\u00e4ckliga bevis f\u00f6r systemiska terapeutiska effekter<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Problematik_der_Bioverfugbarkeit\"><\/span>Problemet med biotillg\u00e4nglighet<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Varf\u00f6r oralt intag \u00e4r problematiskt:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Proteinbindning:<\/strong> Silverjoner binder till proteiner och kloridjoner i matsm\u00e4ltningskanalen<\/li>\n\n\n\n<li><strong>Bildning av AgCl:<\/strong> Sv\u00e5rl\u00f6slig silverklorid bildas i magen<\/li>\n\n\n\n<li><strong>L\u00e5g absorption:<\/strong> Endast en liten andel n\u00e5r blodomloppet<\/li>\n\n\n\n<li><strong>Snabb eliminering:<\/strong> Om galla och njurar<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Farmakokinetiska studier:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Loeschner et al (2011)<\/strong> i <em>Partikel- och fibertoxikologi<\/em>: Unders\u00f6kning av f\u00f6rdelningen av oralt intagna silvernanopartiklar hos r\u00e5ttor - l\u00e5g systemisk biotillg\u00e4nglighet<\/li>\n\n\n\n<li><strong>Van der Zande et al (2012)<\/strong> i <em>ACS Nano<\/em>Absorption av silvernanopartiklar &lt;1% av den orala dosen<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Regulatorische_Position\"><\/span>Reglerande st\u00e4llning<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>FDA (USA):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Klassificerar kolloidalt silver som \u201einte s\u00e4kert och effektivt\u201c f\u00f6r medicinsk anv\u00e4ndning<\/li>\n\n\n\n<li>F\u00f6rbud mot sjukv\u00e5rdsers\u00e4ttningar sedan 1999<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>EMA (Europa):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Inga godk\u00e4nda orala silverpreparat f\u00f6r systemiska infektioner<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>BfR (Tyskland):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Varning f\u00f6r okontrollerat intag<\/li>\n\n\n\n<li>Ingen vetenskaplig grund f\u00f6r terapeutiska p\u00e5st\u00e5enden<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Dokumentierte_Risiken_bei_oraler_Einnahme\"><\/span>Dokumenterade risker med oralt intag<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Argyrie:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Wadhera &amp; Fung (2005)<\/strong> i <em>Amerikansk tidskrift f\u00f6r klinisk dermatologi<\/em>: Dokumentation av argyriafall efter oralt intag av silver<\/li>\n\n\n\n<li>Irreversibel bl\u00e5gr\u00e5 missf\u00e4rgning av huden<\/li>\n\n\n\n<li>Redan m\u00f6jligt med kumulativa doser p\u00e5 1-5 g silver<\/li>\n\n\n\n<li><strong>Exempel p\u00e5 ber\u00e4kning:<\/strong> Vid 10 ppm och 50 mL dagligen = 0,5 mg\/dag \u2192 kritisk ackumulering m\u00f6jlig efter 5-10 \u00e5r<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Andra dokumenterade biverkningar:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Neurologiska symtom (s\u00e4llsynta)<\/li>\n\n\n\n<li>Interaktion med medicinering (antibiotika, tyroxin)<\/li>\n\n\n\n<li>Eventuell f\u00f6r\u00e4ndring av tarmfloran<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Gulbranson et al (2000)<\/strong> i <em>Tidskrift f\u00f6r toxikologi<\/em>Fallbeskrivningar av biverkningar efter l\u00e5ngvarig oral administrering<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Gold_Au\"><\/span>Kolloidalt guld (Au)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftlicher_Stand\"><\/span>Vetenskaplig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Medicinskt erk\u00e4nda applikationer:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Guldf\u00f6reningar (icke-kolloidalt guld) anv\u00e4nds terapeutiskt:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Auranofin och guldnatriumtiomalat:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Godk\u00e4nt l\u00e4kemedel mot reumatoid artrit<\/li>\n\n\n\n<li><strong>Finkelstein et al (1976)<\/strong> i <em>Annaler f\u00f6r internmedicin<\/em>: Kliniska studier av guldbaserade antireumatiska l\u00e4kemedel<\/li>\n\n\n\n<li><strong>Viktigt:<\/strong> Dessa \u00e4r definierade kemiska f\u00f6reningar, inte kolloidala suspensioner<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Gold_%E2%80%93_Evidenzlage\"><\/span>Kolloidalt guld - evidensbas<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Tillg\u00e4nglig forskning:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Tillf\u00e4lliga observationer:<\/strong> N\u00e5gra historiska rapporter fr\u00e5n naturopati<\/li>\n\n\n\n<li><strong>In vitro:<\/strong> Guldnanopartiklar visar antiinflammatoriska egenskaper i cellkulturer<\/li>\n\n\n\n<li><strong>Studier p\u00e5 m\u00e4nniska:<\/strong> Inga publicerade RCT-studier p\u00e5 kolloidalt guld som intas oralt<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Brown et al (2010)<\/strong> i <em>Nanomedicin<\/em>Genomg\u00e5ng av guldnanopartiklar inom medicin - fokus p\u00e5 l\u00e4kemedelstillf\u00f6rsel och diagnostik, inte p\u00e5 direkt terapeutisk effekt vid oralt intag<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Bioverfugbarkeit_und_Pharmakokinetik\"><\/span>Biotillg\u00e4nglighet och farmakokinetik<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Absorption:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Nanopartiklar av guld absorberas knappt i mag-tarmkanalen<\/li>\n\n\n\n<li><strong>Hillyer &amp; Albrecht (2001)<\/strong> i <em>Tidskrift f\u00f6r farmaceutisk vetenskap<\/em>&lt;1% oral biotillg\u00e4nglighet f\u00f6r nanopartiklar<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Ingen fastst\u00e4lld terapeutisk dos<\/strong> f\u00f6r kolloidalt guld n\u00e4r det tas oralt<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"24_Sicherheitsprofil\"><\/span>2.4 S\u00e4kerhetsprofil<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Kategoriseras generellt som s\u00e4krare \u00e4n silver:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ingen risk f\u00f6r ackumulering som med silver (ingen \u201egoldosis\u201c)<\/li>\n\n\n\n<li>L\u00e5g toxicitet vid typiska koncentrationer<\/li>\n\n\n\n<li>Men inte heller n\u00e5gon bevisad effekt n\u00e4r den tas oralt<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Kupfer_Cu\"><\/span>Kolloidal koppar (Cu)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftlicher_Stand-2\"><\/span>Vetenskaplig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Koppar som ett viktigt sp\u00e5r\u00e4mne:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Koppar \u00e4r ett n\u00f6dv\u00e4ndigt n\u00e4rings\u00e4mne (RDA: 0,9 mg\/dag f\u00f6r vuxna), men:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Normal kost t\u00e4cker behoven<\/li>\n\n\n\n<li>Tillskott \u00e4r bara meningsfullt om det finns en bevisad brist<\/li>\n\n\n\n<li><strong>Turnlund et al (1998)<\/strong> i <em>American Journal of Clinical Nutrition<\/em>: Studier av kopparhomeostas<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_vs_ionisches_Kupfer\"><\/span>Kolloidal kontra jonisk koppar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Problemet med differentiering:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>M\u00e5nga \u201ekolloidala\u201c kopparprodukter inneh\u00e5ller fr\u00e4mst jonisk koppar (Cu\u00b2\u207a)<\/li>\n\n\n\n<li>\u00c4kta kolloidala partiklar (Cu\u2070) \u00e4r instabila och oxiderar snabbt<\/li>\n\n\n\n<li>Ingen vetenskaplig litteratur om den medicinska effekten av specifikt kolloidal koppar n\u00e4r den tas oralt<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Toxizitatsrisiko\"><\/span>Toxicitetsrisk<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Koppar har ett smalt terapeutiskt f\u00f6nster:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>\u00d6verdosering:<\/strong> &gt;10 mg\/dag kan leda till toxicitet<\/li>\n\n\n\n<li><strong>Wilsons sjukdom:<\/strong> Genetisk st\u00f6rning med kopparackumulering - kontraindicerat<\/li>\n\n\n\n<li><strong>Gastrointestinala symtom:<\/strong> Illam\u00e5ende, kr\u00e4kningar vid h\u00f6gre doser<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Institutet f\u00f6r medicin (2001)<\/strong>Tolerabelt \u00f6vre intag = 10 mg\/dag<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Zink_Zn\"><\/span>Kolloidal zink (Zn)<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftlicher_Stand-3\"><\/span>Vetenskaplig status<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Zink som ett viktigt sp\u00e5r\u00e4mne:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">V\u00e4ldokumenterad betydelse f\u00f6r immunf\u00f6rsvaret (RDA: 11 mg\/dag f\u00f6r m\u00e4n, 8 mg\/dag f\u00f6r kvinnor)<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Evidenz_fur_Zink-Supplementierung_nicht_spezifisch_kolloidal\"><\/span>Bevis till f\u00f6rm\u00e5n f\u00f6r zinktillskott (inte specifikt kolloidalt)<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>F\u00f6rkylning:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hemil\u00e4 et al (2017)<\/strong> i <em>Cochrane-databasen<\/em>: Metaanalys av zinkpastiller mot f\u00f6rkylning\n<ul class=\"wp-block-list\">\n<li>Resultat: F\u00f6rkortning av f\u00f6rkylningstiderna med ca 33%<\/li>\n\n\n\n<li><strong>Viktigt:<\/strong> I studierna anv\u00e4ndes zinkacetat eller zinkglukonat, inte kolloidal zink<\/li>\n\n\n\n<li>Dosering: 75-100 mg\/dag vid vanlig f\u00f6rkylning<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Immunf\u00f6rsvarets funktion:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Prasad (2008)<\/strong> i <em>Journal of Trace Elements in Medicine and Biology<\/em>Zink f\u00f6rb\u00e4ttrar immunf\u00f6rsvaret vid brist<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kolloidales_Zink_spezifisch\"><\/span>Kolloidal zink specifik<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Avsaknad av bevis:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Inga publicerade studier som j\u00e4mf\u00f6r kolloidal zinkform med andra former<\/li>\n\n\n\n<li>Inga bevis f\u00f6r att kolloidal zink har f\u00f6rdelar j\u00e4mf\u00f6rt med konventionella zinktillskott<\/li>\n\n\n\n<li>Biotillg\u00e4nglighet troligen lika eller s\u00e4mre \u00e4n etablerade former (citrat, glukonat)<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Risiken\"><\/span>Risker<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u00d6verdosering:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>St\u00f6rning av kopparabsorptionen vid &gt;50 mg\/dag under l\u00e5ng tid<\/li>\n\n\n\n<li>Gastrointestinala besv\u00e4r<\/li>\n\n\n\n<li>Tolerabel \u00f6vre gr\u00e4ns: 40 mg\/dag (Institute of Medicine)<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Andere_metallische_Kolloide\"><\/span>Andra metallkolloider<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Platin_Palladium_andere_Edelmetalle\"><\/span>Platina, palladium, andra \u00e4delmetaller<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vetenskaplig litteratur:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Praktiskt taget inga publicerade studier p\u00e5 m\u00e4nniska vid oral administrering<\/li>\n\n\n\n<li>N\u00e5gra in vitro-studier av de antioxidativa egenskaperna hos platina-nanopartiklar<\/li>\n\n\n\n<li><strong>Inga etablerade terapeutiska till\u00e4mpningar<\/strong> n\u00e4r det tas oralt<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Nicht-metallische_Kolloide\"><\/span>Icke-metalliska kolloider<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Micell\u00e4ra vitaminpreparat:<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Detta \u00e4r en legitim farmaceutisk till\u00e4mpning av kolloidteknologi:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Goncalves et al (2021)<\/strong> i <em>N\u00e4rings\u00e4mnen<\/em>F\u00f6rb\u00e4ttrad biotillg\u00e4nglighet av fettl\u00f6sliga vitaminer genom miceller<\/li>\n\n\n\n<li>Kliniskt relevant anv\u00e4ndning vid malabsorption<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Zusammenfassende_Evidenztabelle\"><\/span>Sammanfattad tabell \u00f6ver bevis<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>kolloid<\/th><th>RCT-bevis<\/th><th>Aktivitet in vitro<\/th><th>Oral biotillg\u00e4nglighet<\/th><th>Till\u00e5ten medicinsk anv\u00e4ndning oral<\/th><th>S\u00e4kerhetsproblem<\/th><\/tr><\/thead><tbody><tr><td><strong>Silver<\/strong><\/td><td>Ingen<\/td><td>H\u00f6g (antimikrobiell)<\/td><td>Mycket l\u00e5g (&lt;1%)<\/td><td>Ingen<\/td><td>H\u00f6g (argyria)<\/td><\/tr><tr><td><strong>Guld<\/strong><\/td><td>Ingen<\/td><td>Agens (antiinflammatoriskt)<\/td><td>Mycket l\u00e5g (&lt;1%)<\/td><td>Ingen (kolloidal form)<\/td><td>L\u00e5g<\/td><\/tr><tr><td><strong>koppar<\/strong><\/td><td>Ingen (som kolloid)<\/td><td>N\/A<\/td><td>Ok\u00e4nd<\/td><td>Endast i h\u00e4ndelse av ett bevisat fel<\/td><td>Medelh\u00f6g (toxicitet)<\/td><\/tr><tr><td><strong>Zink<\/strong><\/td><td>Ja (andra former)<\/td><td>N\/A<\/td><td>F\u00f6rmodligen l\u00e5g<\/td><td>Ja (som salt, inte kolloid)<\/td><td>\u00c5tg\u00e4rd (i h\u00e4ndelse av \u00f6verdosering)<\/td><\/tr><tr><td><strong>Platina\/\u00f6vrigt<\/strong><\/td><td>Ingen<\/td><td>Svag<\/td><td>Ok\u00e4nd<\/td><td>Ingen<\/td><td>Ok\u00e4nd<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warum_gibt_es_so_wenig_klinische_Forschung\"><\/span>Varf\u00f6r finns det s\u00e5 lite klinisk forskning?<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Strukturelle_Grunde\"><\/span>Strukturella orsaker<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Avsaknad av patenterbarhet:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Naturliga element kan inte patenteras<\/li>\n\n\n\n<li>Inga ekonomiska incitament f\u00f6r dyra kliniska pr\u00f6vningar (fas I-III kostar 100+ miljoner euro)<\/li>\n\n\n\n<li>L\u00e4kemedelsf\u00f6retag investerar inte utan exklusiva r\u00e4ttigheter<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Lagstiftningsm\u00e4ssiga hinder:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Oklar klassificering (kosttillskott vs. l\u00e4kemedel)<\/li>\n\n\n\n<li>Standardiseringsproblem (varierande partikelstorlekar, koncentrationer)<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Metodologiska utmaningar:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sv\u00e5rt att bl\u00e4nda (f\u00e4rg!)<\/li>\n\n\n\n<li>Kvalitetskontroll av test\u00e4mnet<\/li>\n\n\n\n<li>L\u00e5ngsiktiga s\u00e4kerhetsstudier kr\u00e4vs<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Was_bedeutet_das_fur_die_Interpretation\"><\/span>Vad inneb\u00e4r detta f\u00f6r tolkningen?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Avsaknad av bevis \u2260 Bevis f\u00f6r avsaknad<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Avsaknaden av RCT-studier inneb\u00e4r inte n\u00f6dv\u00e4ndigtvis att kolloidala metaller \u00e4r ineffektiva. Det betyder det:<\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Vi har ingen vetenskapligt robust bekr\u00e4ftelse p\u00e5 effekt<\/li>\n\n\n\n<li>Vi kan inte ge evidensbaserade doseringsrekommendationer<\/li>\n\n\n\n<li>L\u00e5ngtidss\u00e4kerheten har inte unders\u00f6kts systematiskt<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Praktische_Konzentrationen_in_kommerziellen_Produkten\"><\/span>Praktiska koncentrationer i kommersiella produkter<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Typiska koncentrationer p\u00e5 marknaden:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Kolloidalt silver:<\/strong> 5-50 ppm (vissa upp till 500 ppm)<\/li>\n\n\n\n<li><strong>Kolloidalt guld:<\/strong> 10-30 ppm<\/li>\n\n\n\n<li><strong>Andra metaller:<\/strong> 10-50 ppm<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Sedvanlig doseringsinformation (tillverkarens anvisningar, ej evidensbaserad):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>1-3 teskedar (5-15 ml) dagligen<\/li>\n\n\n\n<li>Vid 10 ppm = 0,05-0,15 mg metall per dag<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Vetenskaplig utv\u00e4rdering av dessa doser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>F\u00f6r silver och guld: F\u00f6rmodligen f\u00f6r l\u00e5g f\u00f6r systemisk effekt med d\u00e5lig biotillg\u00e4nglighet<\/li>\n\n\n\n<li>F\u00f6r viktiga sp\u00e5r\u00e4mnen (Zn, Cu): Betydligt under RDA<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Topische_vs_orale_Anwendung_%E2%80%93_ein_wichtiger_Unterschied\"><\/span>Topikal vs. oral applicering - en viktig skillnad<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Belegte_topische_Anwendungen\"><\/span>Bepr\u00f6vade topiska till\u00e4mpningar<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Silver i s\u00e5rbehandling:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Vermeulen m.fl. (2007)<\/strong> i <em>Cochrane-databasen<\/em>Systematisk genomg\u00e5ng av silverinneh\u00e5llande s\u00e5rf\u00f6rband<\/li>\n\n\n\n<li><strong>Resultat:<\/strong> M\u00e5ttlig evidens f\u00f6r effekt vid infekterade s\u00e5r<\/li>\n\n\n\n<li><strong>Mekanism:<\/strong> Direktkontakt med bakterier, ingen systemisk absorption kr\u00e4vs<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>koncentrationer topiskt:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Medicinska s\u00e5rf\u00f6rband: 50-100 ppm silver<\/li>\n\n\n\n<li>Direkt antimikrobiell kontakt<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warum_funktioniert_topisch_aber_nicht_oral\"><\/span>Varf\u00f6r fungerar topikalt men inte oralt?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Avg\u00f6rande skillnader:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Direkt kontakt:<\/strong> Silverjoner har en direkt topikal effekt p\u00e5 bakterier<\/li>\n\n\n\n<li><strong>Ingen GI-inaktivering:<\/strong> Inget pH-v\u00e4rde i mags\u00e4cken, ingen proteinbindning<\/li>\n\n\n\n<li><strong>Lokal koncentration:<\/strong> H\u00f6g koncentration p\u00e5 platsen d\u00e4r \u00e5tg\u00e4rden utf\u00f6rs m\u00f6jlig<\/li>\n\n\n\n<li><strong>Biotillg\u00e4nglighet irrelevant:<\/strong> Systemisk absorption kr\u00e4vs inte<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kritische_Bewertung_von_Anekdoten_und_Erfahrungsberichten\"><\/span>Kritisk utv\u00e4rdering av anekdoter och f\u00e4ltrapporter<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Warum_personliche_Berichte_nicht_ausreichen\"><\/span>Varf\u00f6r personliga rapporter inte \u00e4r tillr\u00e4ckliga<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Placeboeffekt:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>F\u00f6r subjektiva symtom (tr\u00f6tthet, sm\u00e4rta) \u00e4r placebosvarsfrekvensen ofta 30-40%<\/li>\n\n\n\n<li><strong>Finniss et al (2010)<\/strong> i <em>Lansett<\/em>: Granskning av placeboeffekter<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Spontan remission:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>M\u00e5nga sjukdomar (f\u00f6rkylningar, lindriga infektioner) l\u00e4ker spontant<\/li>\n\n\n\n<li>Tidsm\u00e4ssigt samband \u2260 Kausalitet<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Bekr\u00e4ftelsebias:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ben\u00e4genhet att minnas och rapportera positiva upplevelser<\/li>\n\n\n\n<li>Negativa upplevelser dokumenteras mer s\u00e4llan<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Publikationens partiskhet:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Det \u00e4r mer sannolikt att positiva resultat offentligg\u00f6rs \u00e4n negativa<\/li>\n\n\n\n<li>M\u00e5nga sm\u00e5 studier med negativa resultat f\u00f6rblir opublicerade<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Was_ware_notig_fur_Evidenz\"><\/span>Vad skulle beh\u00f6vas f\u00f6r bevis?<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Randomiserade, placebokontrollerade, dubbelblinda studier med:<\/strong><\/p>\n\n\n\n<ol class=\"wp-block-list\">\n<li>Tillr\u00e4ckligt antal deltagare (power-analys)<\/li>\n\n\n\n<li>Objektiva effektm\u00e5tt (inte bara subjektiva symtom)<\/li>\n\n\n\n<li>Standardiserad produkt (definierad partikelstorlek, koncentration)<\/li>\n\n\n\n<li>Peer-reviewed publikation<\/li>\n\n\n\n<li>Replikering av oberoende forskare<\/li>\n<\/ol>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>S\u00e5dana studier finns f\u00f6r n\u00e4rvarande inte f\u00f6r oralt intag av metallkolloider.<\/strong><\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Wissenschaftliche_Quellen_fur_weitere_Recherche\"><\/span>Vetenskapliga k\u00e4llor f\u00f6r vidare forskning<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rekommenderade databaser:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>PubMed\/MEDLINE:<\/strong> pubmed.ncbi.nlm.nih.gov\n<ul class=\"wp-block-list\">\n<li>S\u00f6kord: \u201ekolloidalt silver oralt\u201c, \u201esilvernanopartiklar intag\u201c, \u201eguldnanopartiklar oral biotillg\u00e4nglighet\u201c<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Cochrane-biblioteket:<\/strong> cochranelibrary.com\n<ul class=\"wp-block-list\">\n<li>Systematiska \u00f6versikter och metaanalyser (guldstandard)<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Web of Science:<\/strong> webofscience.com\n<ul class=\"wp-block-list\">\n<li>Analys av citeringar, p\u00e5verkansfaktorer<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Viktiga \u00f6versiktsartiklar:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Hadrup &amp; Lam (2014):<\/strong> \u201eOral toxicitet av silverjoner, silvernanopartiklar och kolloidalt silver - En \u00f6versikt\u201c i <em>Reglerande toxikologi och farmakologi<\/em><\/li>\n\n\n\n<li><strong>Fung &amp; Bowen (1996):<\/strong> \u201eSilverprodukter f\u00f6r medicinska indikationer: risk-nyttabed\u00f6mning\u201c i <em>Tidskrift f\u00f6r toxikologi<\/em><\/li>\n\n\n\n<li><strong>Lansdown (2006):<\/strong> \u201eSilver inom sjukv\u00e5rden: antimikrobiella effekter och s\u00e4ker anv\u00e4ndning\u201c i <em>Biofunktionella textilier och huden<\/em><\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Fazit\"><\/span>Slutsats<span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Kernaussagen\"><\/span>Viktiga budskap<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Det finns inga robusta kliniska studier av oralt intag av metallkolloider (s\u00e4rskilt silver och guld)<\/strong>, som skulle bevisa medicinsk effekt i enlighet med standarderna f\u00f6r evidensbaserad medicin.<\/li>\n\n\n\n<li><strong>In vitro-aktivitet (i laboratoriet) \u00e4r v\u00e4ldokumenterad<\/strong>, s\u00e4rskilt f\u00f6r silver, men <strong>Kan inte \u00f6verf\u00f6ras till oralt intag<\/strong> p\u00e5 grund av extremt l\u00e5g biotillg\u00e4nglighet.<\/li>\n\n\n\n<li><strong>Topikal applicering av silver<\/strong> inom s\u00e5rbehandling \u00e4r <strong>Vetenskapligt bevisad<\/strong> - H\u00e4r fungerar det genom direktkontakt.<\/li>\n\n\n\n<li><strong>Risker i samband med l\u00e5ngvarig oral administrering \u00e4r dokumenterade<\/strong>, s\u00e4rskilt argyria i silver.<\/li>\n\n\n\n<li><strong>Bristen p\u00e5 bevis \u00e4r fr\u00e4mst ett forskningsproblem<\/strong>, Detta \u00e4r inte n\u00f6dv\u00e4ndigtvis ett bevis p\u00e5 ineffektivitet - det finns helt enkelt en brist p\u00e5 h\u00f6gkvalitativa studier.<\/li>\n<\/ol>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Empfehlungen_aus_wissenschaftlicher_Sicht\"><\/span>Rekommendationer ur ett vetenskapligt perspektiv<span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Om du vill ta metallkolloider oralt:<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>R\u00e5dg\u00f6r med l\u00e4kare, s\u00e4rskilt om du har n\u00e5gon befintlig sjukdom<\/li>\n\n\n\n<li>Var medveten om att du har en <strong>inte evidensbaserad<\/strong> V\u00e4lj behandling<\/li>\n\n\n\n<li>\u00d6vervaka eventuella biverkningar<\/li>\n\n\n\n<li>F\u00f6rv\u00e4nta dig inte en \u201emirakeleffekt\u201c<\/li>\n\n\n\n<li>Ers\u00e4tter inte evidensbaserade behandlingar<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>F\u00f6r viktiga sp\u00e5r\u00e4mnen (zink, koppar):<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Konventionella preparat \u00e4r b\u00e4ttre studerade och f\u00f6rmodligen mer bioaktiva<\/li>\n\n\n\n<li>Om du misst\u00e4nker en brist ska du f\u00f6rst l\u00e5ta best\u00e4mma en blodniv\u00e5<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Det vetenskapligt \u00e4rliga svaret \u00e4r:<\/strong> Vi vet inte s\u00e4kert eftersom de n\u00f6dv\u00e4ndiga studierna aldrig har genomf\u00f6rts. Tillg\u00e4ngliga data tyder p\u00e5 att den orala biotillg\u00e4ngligheten \u00e4r f\u00f6r l\u00e5g f\u00f6r systemiska terapeutiska effekter, men definitiva bevis i form av RCT-studier saknas.<\/p>","protected":false},"excerpt":{"rendered":"<p>Diese Abhandlung basiert auf ver\u00f6ffentlichten wissenschaftlichen Studien. Es ist entscheidend zu verstehen, dass das Fehlen klinischer Evidenz nicht bedeutet, dass etwas unwirksam ist, sondern lediglich, dass keine ausreichenden wissenschaftlich kontrollierten Studien durchgef\u00fchrt wurden oder bisherige Studien keine eindeutigen Ergebnisse erbracht haben. Alle &#8222;Heim&#8220;-Generatoren erzeugen nur ionisiertes Wasser &#8211; keine Kolloide! Mangels f\u00fcr Laien verf\u00fcgbare laborzertifizierter&hellip;&nbsp;<a href=\"https:\/\/csiag.de\/sv\/blog\/2026\/01\/28\/kolloide-sicher-wirksam-oder-nicht\/\" rel=\"bookmark\">L\u00e4s mer \"<span class=\"screen-reader-text\">Kolloider - s\u00e4kert effektiva eller inte?<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_lmt_disableupdate":"","_lmt_disable":"","neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[1],"tags":[],"class_list":["post-12526","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"modified_by":"Achim Goerner","_links":{"self":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts\/12526","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/comments?post=12526"}],"version-history":[{"count":0,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/posts\/12526\/revisions"}],"wp:attachment":[{"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/media?parent=12526"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/categories?post=12526"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/csiag.de\/sv\/wp-json\/wp\/v2\/tags?post=12526"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}